NL-OMON30733已完成3 期
EValuation Of Cinacalcet HCL Therapy to Lower CardioVascular Events - EVOLVE
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Amgen
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •>= 18 years of age
- •treated with maintenance hemodialysis 3 times a week for >= 3 months before randomization
- •PTH >= 31.8 mmol/L
- •Ca >= 2.1 mmol/L
- •Ca x P >= 3.63 mmol/L
排除标准
- •Parathyroidectomy in the 12 weeks prior to randomization
- •received therapy with cinacalcet within 3 months of randomization
- •Hospitalization within 12 weeks of randomization for any of the following events:
- •b. Unstable angina
- •d. Peripheral vascular disease
- •History of seizure within 12 weeks prior to randomization
- •Scheduled date for kidney transplant from a known living donor
- •Anticipated parathyroidectomy within 6 months after randomization.
研究者
相似试验
进行中（未招募）
1 期
Study to Investigate Cinacalcet Treatment in Haemodialysis Patients with Secondary Hyperparathyroidism - SENSOREUCTR2004-002310-10-ESAmgen Development Europe800
已完成
不适用
Prospective Study on the effects of cinacalcet HCL on vascular calcification and parathyroid glands size in patients on maintenance hemodialysischronic kidney disease patients with hyperparathyroidism undergoing hemodialysisJPRN-UMIN000002628Division of Nephrology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine60
进行中（未招募）
不适用
EVOLVE - Evaluation Of Cinacalcet HCl Therapy to Lower Cardiovascular Events - EVOLVEEUCTR2006-002075-40-PTAmgen Inc.3,800
进行中（未招募）
不适用
EVOLVE - Evaluation Of Cinacalcet HCl Therapy to Lower Cardiovascular Events - EVOLVESecondary hyperparathyroidism (HPT) in subjects with chronic kidney disease (CKD) receiving maintenance hemodialysis.MedDRA version: 8.1Level: LLTClassification code 10020708Term: Hyperparathyroidism secondaryEUCTR2006-002075-40-DKAmgen Inc.3,800
进行中（未招募）
不适用
EVOLVE - Evaluation Of Cinacalcet HCl Therapy to Lower Cardiovascular Events - EVOLVESecondary hyperparathyroidism (HPT) in subjects with chronic kidney disease (CKD) receiving maintenance hemodialysis.MedDRA version: 8.1Level: LLTClassification code 10020708Term: Hyperparathyroidism secondaryEUCTR2006-002075-40-IEAmgen Inc.3,800